P/E ratio for Mallinckrodt Pharmaceuticals (MNK)

P/E ratio history for Mallinckrodt Pharmaceuticals from 2022 to 2023

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Johnson & Johnson JNJ	10.9	-389,759.43%	🇺🇸 USA
Zogenix ZGNX	-6.56	233,208.06%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	-8.27	294,325.40%	🇮🇱 Israel
General Electric GE	20.6	-733,207.69%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.